CBDA has shown to have a more intense activation of 5-HT1A serotonin receptors compared to CBD. 

Based on the current research, CBDA’s potential as a medicine is still up in the air. 

Up until now, clinical trials have largely focused on animal models. Until trials focus on human health and how CBDA works, we will not know the full extent of CBDA’s power.

*These statements have not been evaluated by the FDA and are not intended to treat or cure any diseases.